The World Health Organization reports that around the world, people acquire more than a million curable sexually transmitted infections (STIs) every day. Most of those STIs, however, are asymptomatic.

Novel approach analyzes thousands of red blood cells from a small sample, showcasing the long-term potential of microfluidics for testing across conditions Using advanced microfluidic technology, our ...

Some 300,000 people in the U.S. are diagnosed with Lyme disease every year. Caused by Borrelia burgdorferi and transmitted by the bite of infected Ixodes ticks, the disease if left untreated can cause ...

Can you explain how Bartels Mikrotechnik’s experience benefits clients looking for a fast entry into microfluidic applications? Bartels Mikrotechnik has over 26 years of experience in the ...

MEMS devices based on microfluidics�the movement of minute amounts of liquids through microchannels�promise a new era of life-saving diagnostic and drug-delivery systems, as well as new ...

Current testing for Lyme disease, called the standard 2-tiered approach or the STT, involves running two complex assays (ELISA and western blot) to detect antibodies against the bacterium, and ...

Spike proteins: artist’s impression of the virus that causes COVID-19 (Courtesy: iStock/RomoloTavani) A rapid and low-cost test for the virus that causes COVID-19 has been developed by researchers in ...

LONDON, March 20, 2017 /PRNewswire/ -- With 14.5% CAGR, point of care testing segment is the largest segment among the global microfluidics market application segments By the end of 2026, the point of ...

Viable bacteria in the blood, i.e., bacteremia, can lead to bloodstream infection (BSI) and sepsis, a syndromic, often fatal, inflammatory response. Rapid and accurate antimicrobial prescriptions are ...